During the past decade, Hospital Nacional; Arzobispo Loayza conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 7 clinical trials were completed, i.e. on average, 46.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Nacional; Arzobispo Loayza" #1 sponsor was "Universidad Peruana Cayetano Heredia" with 4 trials, followed by "Merck Sharp & Dohme LLC" with 2 trials sponsored, "Sunovion" with 2 trials sponsored, "University of Minnesota" with 2 trials sponsored and "Astellas Pharma Global Development, Inc." with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Nacional; Arzobispo Loayza" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Cardiokine Biopharma, LLC" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Nacional; Arzobispo Loayza" are "Influenza" (3 trials), "Bipolar Depression" (2 trials), "Chronic Cough" (2 trials), "Advanced Cholangiocarcinoma" (1 trials) and "Amyloidosis" (1 trials). Many other conditions were trialed in "Hospital Nacional; Arzobispo Loayza" in a lesser frequency.

Most popular intervention types in "Hospital Nacional; Arzobispo Loayza" are "Drug" (17 trials), "Behavioral" (3 trials), "Device" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Gefapixant" (2 trials), "1% Glycated Chitosan" (1 trials), "40 mg Laninamivir Octanoate" (1 trials) and "80 mg Laninamivir Octanoate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Nacional; Arzobispo Loayza" are 22 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Nacional; Arzobispo Loayza". 1 are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Hospital Nacional; Arzobispo Loayza, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Nacional; Arzobispo Loayza, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".